Plus Therapeutics Q3 EPS $(0.04) Misses $(0.02) Estimate, Sales $1.397M Miss $1.500M Estimate

Author: Benzinga Newsdesk | October 30, 2025 03:28pm
Plus Therapeutics (NASDAQ:PSTV) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.02) by 100 percent. This is a 89.19 percent increase over losses of $(0.37) per share from the same period last year. The company reported quarterly sales of $1.397 million which missed the analyst consensus estimate of $1.500 million by 6.87 percent. This is a 4.05 percent decrease over sales of $1.456 million the same period last year.

Posted In: PSTV